(WIAT) — Do you or someone you know suffer from Obsessive Compulsive Disorder (OCD)? If so, there is a new study looking for participants searching for relief.
Biohaven Pharmaceuticals is looking for participants from ages 18 to 65 who suffer from the disorder.
OCD affects 1 in 100 people and some do not experience relief with common medication. Biohaven is looking to study the effects of a new medication.
This investigational medication targets glutamate, a chemical in the brain that is believed to contribute to OCD. There is no cost to participate, and you may be compensated for your time and travel.
If you would like to learn more or apply to be a participant, click here.